Artal Group’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-300,000
| Closed | -$3.6M | – | 131 |
|
|
2022
Q2 | $3.6M | Hold |
300,000
| – | – | 0.19% | 73 |
|
|
2022
Q1 | $3.93M | Hold |
300,000
| – | – | 0.16% | 89 |
|
|
2021
Q4 | $5.28M | Hold |
300,000
| – | – | 0.14% | 94 |
|
|
2021
Q3 | $6.51M | Hold |
300,000
| – | – | 0.15% | 96 |
|
|
2021
Q2 | $10.5M | Buy |
300,000
+60,000
| +25% | +$2.1M | 0.21% | 80 |
|
|
2021
Q1 | $23.7M | Sell |
240,000
-10,000
| -4% | -$986K | 0.42% | 44 |
|
|
2020
Q4 | $27.1M | Buy |
250,000
+70,000
| +39% | +$7.59M | 0.58% | 42 |
|
|
2020
Q3 | $18.5M | Buy |
180,000
+90,000
| +100% | +$9.27M | 0.45% | 40 |
|
|
2020
Q2 | $18.8M | Buy |
90,000
+30,000
| +50% | +$6.26M | 0.53% | 36 |
|
|
2020
Q1 | $5.86M | Buy |
+60,000
| New | +$5.86M | 0.25% | 60 |
|
|
2018
Q4 | – | Sell |
-40,000
| Closed | -$2.42M | – | 81 |
|
|
2018
Q3 | $2.42M | Hold |
40,000
| – | – | 0.06% | 74 |
|
|
2018
Q2 | $2.12M | Hold |
40,000
| – | – | 0.05% | 70 |
|
|
2018
Q1 | $2.32M | Buy |
+40,000
| New | +$2.32M | 0.03% | 64 |
|
|
2015
Q2 | – | Sell |
-10,000
| Closed | -$4.05M | – | 43 |
|
|
2015
Q1 | $4.05M | Buy |
+10,000
| New | +$4.05M | 0.19% | 41 |
|